S&P 500 Futures
(0.22%) 5 533.50 points
Dow Jones Futures
(0.15%) 39 527 points
Nasdaq Futures
(0.24%) 19 976 points
Oil
(0.67%) $82.09
Gas
(-2.04%) $2.55
Gold
(0.14%) $2 342.90
Silver
(0.19%) $29.62
Platinum
(-0.56%) $996.30
USD/EUR
(-0.28%) $0.931
USD/NOK
(-0.27%) $10.65
USD/GBP
(-0.13%) $0.790
USD/RUB
(1.95%) $87.40

实时更新: Prophase Labs Inc [PRPH]

交易所: NASDAQ 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间29 Jun 2024 @ 04:00

-2.11% $ 4.18

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is overvalued by -0.91% compare to its pairs and should correct downwards.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States...

Stats
今日成交量 36 911
平均成交量 60 653
市值 79.75M
EPS $-0.350 ( Q1 | 2024-05-10 )
下一个收益日期 ( $-0.250 ) 2024-08-08
Last Dividend $0.300 ( 2022-05-24 )
Next Dividend $0 ( N/A )
P/E -3.07
(Sector) 42.63
(Industry) 0
ATR14 $0.0230 (0.55%)
ACOR -24.02%
ACRX 7.50%
ADMP 0.85%
ADMS 0.00%
AGRX -1.40%
AKAN -3.75%
ALIM 0.54%
AMPH -0.87%
AMYT 0.00%
ANIP 0.94%
AQST 0.39%
ASRT -5.34%
ATNX 0.00%
AVDL -1.75%
AYTU 0.00%
BFRI -2.39%
BGXX -34.22%
CLVR -2.22%
COLL -0.74%
CPIX 0.66%
CRDL 1.00%
CRON -0.43%
CYTH 5.83%
DCPH 0.00%
DERM 9.73%
DRRX -5.49%
DVAX -1.23%
EGRX 11.55%
EMBC 0.32%
EMBCV -9.33%
EOLS -0.73%
ESPR -3.90%
EVOK 5.48%
FLGC 6.71%
FLXN 0.00%
GHSI -0.35%
HCM -1.83%
HROW -0.52%
HUGE -4.71%
IMCC 2.20%
INCR 2.03%
IRWD 5.16%
ITCI -3.51%
IXHL 10.53%
JUPW 11.76%
KALA 9.92%
KIN 0.11%
KMDA -1.78%
LNTH -1.25%
NBIX 2.50%
NEPT 0.00%
NLTX 1.45%
OGI -3.75%
OPTN -3.70%
ORGO 6.06%
PAHC -2.50%
PCRX 2.51%
PETQ -0.45%
PLXP 0.00%
PPD 0.00%
PROC -0.40%
PRPH -2.11%
PTPI 2.69%
RDHL -2.58%
RDUS 4.30%
REPH -0.48%
RGC -5.88%
RMTI 0.00%
SCTL 0.92%
SCYX -1.48%
SIGA 3.13%
SISI -13.33%
SNDL -1.04%
SNOA 1.05%
SSIC 1.03%
SUPN -0.45%
SXTC -2.24%
THTX 0.00%
TKNO -1.44%
TLGT -13.85%
TLRY -4.05%
TXMD -7.47%
TYHT -3.90%
UPC -1.97%
VTRS 1.43%
ZYNE 2.36%
Insider Trading
Date Person Action Amount type
2024-03-17 Karkus Ted William Buy 400 000 Option (right to buy)
2024-01-01 Latkin Jed Buy 500 000 Option (right to buy)
2024-01-01 Latkin Jed Buy 0
2024-03-17 Hirsch Warren Buy 70 000 Option (right to buy)
2024-03-17 Gleckel Louis Md Buy 70 000 Option (right to buy)
INSIDER POWER
22.52
Last 98 transactions
Buy: 8 777 863 | Sell: 8 858 292
相关性 (AI algo v.1.1b): Overvalued: -0.91% $4.19 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

Prophase Labs Inc 相关性

10 最正相关
CLRO0.843
LTRN0.834
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Prophase Labs Inc 财务报表

Annual 2023
营收: $44.38M
毛利润: $16.24M (36.59 %)
EPS: $-0.980
FY 2023
营收: $44.38M
毛利润: $16.24M (36.59 %)
EPS: $-0.980
FY 2022
营收: $122.65M
毛利润: $70.65M (57.61 %)
EPS: $1.170
FY 2021
营收: $79.04M
毛利润: $41.99M (53.12 %)
EPS: $0.540

Financial Reports:

No articles found.

Prophase Labs Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Prophase Labs Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1.000 2018-06-06
Last Dividend $0.300 2022-05-24
Next Dividend $0 N/A
Payout Date 2022-06-03
Next Payout Date N/A
# dividends 6 --
Total Paid Out $2.40 --
Avg. Dividend % Per Year 2.00% --
Score 1.36 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-11-07)
$0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
1.36
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2018 $1.000 44.60%
2019 $0.500 15.40%
2020 $0 0.00%
2021 $0.300 2.84%
2022 $0.600 8.10%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
24 May 2022 $0.300 13 May 2022 25 May 2022 03 Jun 2022
28 Feb 2022 $0.300 16 Feb 2022 01 Mar 2022 10 Mar 2022
24 May 2021 $0.300 13 May 2021 25 May 2021 03 Jun 2021
02 Dec 2019 $0.250 20 Nov 2019 03 Dec 2019 12 Dec 2019
09 Jan 2019 $0.250 26 Dec 2018 10 Jan 2019 24 Jan 2019
06 Jun 2018 $1.000 08 May 2018 21 May 2018 05 Jun 2018

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Diamond 2024-09-16 Monthly 14 15.03% 9.60
DMLP Dividend Diamond 2024-04-26 Quarterly 22 10.71% 9.35
OXSQ Dividend Diamond 2024-09-16 Monthly 21 12.73% 9.02
ARLP Dividend Royal 2024-05-07 Quarterly 26 9.67% 8.87
PNNT Dividend Royal 2024-06-14 Monthly 18 9.49% 8.82
MFIC Dividend Royal 2024-06-11 Quarterly 21 10.89% 8.79
SPOK Dividend Royal 2024-05-23 Quarterly 20 8.73% 8.72
PSEC Dividend Royal 2024-06-25 Monthly 21 9.03% 8.65
SBLK Dividend Royal 2024-06-06 Quarterly 17 13.10% 8.63
GBDC Dividend Royal 2024-11-29 Bi-Monthly 15 8.53% 8.62

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.8221.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2621.200-8.74-10.00[0 - 0.3]
returnOnEquityTTM-0.4501.500-6.11-9.16[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.8840.8005.584.46[1 - 3]
quickRatioTTM1.5440.8005.624.50[0.8 - 2.5]
cashRatioTTM0.07261.500-0.708-1.062[0.2 - 2]
debtRatioTTM0.172-1.5007.14-10.00[0 - 0.6]
interestCoverageTTM-19.551.000-8.35-8.35[3 - 30]
operatingCashFlowPerShareTTM-0.9392.00-0.313-0.626[0 - 30]
freeCashFlowPerShareTTM-1.1372.00-0.569-1.137[0 - 20]
debtEquityRatioTTM0.345-1.5008.62-10.00[0 - 2.5]
grossProfitMarginTTM0.1841.000-0.265-0.265[0.2 - 0.8]
operatingProfitMarginTTM-1.0721.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.0951.000-7.19-7.19[0.2 - 2]
assetTurnoverTTM0.3190.800-1.207-0.966[0.5 - 2]
Total Score-3.16

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-3.201.000-0.4240[1 - 100]
returnOnEquityTTM-0.4502.50-3.93-9.16[0.1 - 1.5]
freeCashFlowPerShareTTM-1.1372.00-0.379-1.137[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.9392.00-0.313-0.626[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.09241.500-3.950[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.5901.000-10.000[0.1 - 0.5]
Total Score-2.75

Prophase Labs Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Prophase Labs Inc

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 2.011421918869 seconds
Number of API calls: 3
Number of DB calls: 9